Terms: = Liver cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
590 results:
1. In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC.
Singh K; Kumar P; Singh AK; Singh N; Singh S; Tiwari KN; Agrawal S; Das R; Singh A; Ram B; Tripathi AK; Mishra SK
Med Oncol; 2024 Apr; 41(6):130. PubMed ID: 38676780
[TBL] [Abstract] [Full Text] [Related]
2. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
[TBL] [Abstract] [Full Text] [Related]
3. Dual Drug Repurposing: The Example of Saracatinib.
Ramos R; Vale N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674150
[TBL] [Abstract] [Full Text] [Related]
4. Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-src signaling pathways.
Yu CL; Lai YW; Chen JJ; Lee JJ; Chou TH; Huang CC; Liu SC; Chen GW; Tsai CH; Wang SW
J Food Drug Anal; 2023 Dec; 31(4):696-710. PubMed ID: 38526828
[TBL] [Abstract] [Full Text] [Related]
5. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma.
Dong R; Wang T; Dong W; Zhu H; Liu Q; Liang H; Chen X; Zhang B; Zhang X
Biomed Pharmacother; 2024 Apr; 173():116366. PubMed ID: 38458013
[TBL] [Abstract] [Full Text] [Related]
8. Appraisal of folate functionalized bosutinib cubosomes against hepatic cancer cells: In-vitro, In-silico, and in-vivo pharmacokinetic study.
Nisha R; Kumar P; Mishra N; Maurya P; Ahmad S; Singh N; Saraf SA
Int J Pharm; 2024 Apr; 654():123975. PubMed ID: 38452833
[TBL] [Abstract] [Full Text] [Related]
9. Protease-activated receptor 2 drives migration in a colon cancer cell line but not in noncancerous human epithelial cells.
Périco LL; Vegso AJ; Baggio CH; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G525-G542. PubMed ID: 38440826
[TBL] [Abstract] [Full Text] [Related]
10. N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-src kinase inhibitors with prominent antitumor activity.
Awaji AA; Zaloa WAZE; Seleem MA; Alswah M; Elsebaei MM; Bayoumi AH; El-Morsy AM; Alfaifi MY; Shati AA; Elbehairi SEI; Almaghrabi M; Aljohani AKB; Ahmed HEA
Bioorg Chem; 2024 Apr; 145():107228. PubMed ID: 38422592
[TBL] [Abstract] [Full Text] [Related]
11. Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cells.
Cao JL; Li SM; Tang YJ; Hou WS; Wang AQ; Li TZ; Jin CH
Drug Dev Res; 2024 Apr; 85(2):e22165. PubMed ID: 38400652
[TBL] [Abstract] [Full Text] [Related]
12. Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells.
Tang D; Wang H; Deng W; Wang J; Shen D; Wang L; Lu J; Feng Y; Cao S; Li W; Yin P; Xu K; Chen J
Apoptosis; 2024 Jun; 29(5-6):635-648. PubMed ID: 38393643
[TBL] [Abstract] [Full Text] [Related]
13. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/src signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatic Analysis and Computer-Aided Study to Investigate the Potential Application of a Bioflavonoid Compound Bilobetin in liver cancer Treatment.
Zhang C; Sui Y; Liu S; Yang M
Front Biosci (Landmark Ed); 2023 Dec; 28(12):360. PubMed ID: 38179744
[TBL] [Abstract] [Full Text] [Related]
16. A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC.
Zhang X; Zhao Y; Li M; Wang M; Qian J; Wang Z; Wang Y; Wang F; Guo K; Gao D; Zhao Y; Chen R; Ren Z; Song H; Cui J
Cancer Lett; 2024 Feb; 582():216597. PubMed ID: 38145655
[TBL] [Abstract] [Full Text] [Related]
17. Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR-1247-3p-modulated integrin/FAK axis.
Huang CC; Tsai MC; Wu YL; Lee YJ; Yen AT; Wang CJ; Kao SH
Environ Toxicol; 2024 Apr; 39(4):2077-2085. PubMed ID: 38100242
[TBL] [Abstract] [Full Text] [Related]
18. Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells.
Jung YY; Kim C; Shanmugam MK; Deivasigamani A; Chinnathambi A; Alharbi SA; Rangappa KS; Hui KM; Sethi G; Mohan CD; Ahn KS
Cell Signal; 2024 Feb; 114():111003. PubMed ID: 38048857
[TBL] [Abstract] [Full Text] [Related]
19. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
[TBL] [Abstract] [Full Text] [Related]
20. miR-146a-5p Alleviates Radiation-Induced liver Fibrosis by Regulating PTPRA-src Signaling in Mice.
Yuan BY; Zhuang Y; Wu ZF; Zhao XM; Zhang L; Chen GW; Zeng ZC
Radiat Res; 2023 Dec; 200(6):531-537. PubMed ID: 38014555
[TBL] [Abstract] [Full Text] [Related]
[Next]
